Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-56.30	16.70	38.22
Graham Fair Price	46.66	19.39	13.22
PEG	-68.54	0.06	-0.19
Price/Book	3.61	2.03	1.96
Price/Cash Flow	-39.35	40.52	66.80
Prices/Earnings	-48.20	6.15	11.87
Price/Sales	-48.20	4.52	8.72
Price/FCF	-39.35	40.52	66.80
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.69	0.69
Operating Margin	2.16	0.19	0.19
ROA	100.00	0.06	0.03
ROE	0.04	0.08	100.00
ROIC	0.04	0.08	113.74
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.24	-0.19	26.95
Dividends QOQ	-0.56	0.04	-93.41
EBIT QOQ	-0.68	1.04	54.51
EPS QOQ	-0.64	1.05	64.67
FCF QOQ	-0.69	0.71	2.11
Revenue QOQ	-0.51	1.00	96.31
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	225.28	112.64	-50.00
Days Sales Outstanding (DSO)	147.99	70.56	-52.32
Inventory Turnover	0.40	0.80	100.00
Debt/Capitalization	0.06	0.02	-60.04
Quick Ratio	2.53	2.47	-2.50
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	13.73	14.24	3.71
Cash	3.66	3.81	4.20
Capex	-0.03	-0.18	-449.30
Free Cash Flow	0.40	0.71	77.15
Revenue	3.08	6.39	107.41
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	3.47	3.47	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.50	-1.74	61.27
Naive Interpretation	Member

06 - Financial Health · Bad

Rating